|
Role of Inhaled Nitric Oxide in Vascular Mechanics and Right Ventricular Function
RECRUITINGN/ASponsored by Fernando Suarez Sipmann
Actively Recruiting
PhaseN/A
SponsorFernando Suarez Sipmann
Started2023-11-22
Est. completion2024-08
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06097026
Summary
The aim of this study is to evaluate the role of nitric oxide on pulmonary vasculature and right ventricular function in postoperative cardiac surgery patients.
Eligibility
Age: 18 Years+Healthy volunteers accepted
* Age \> 18 years * Under controlled mechanical ventilation in passive conditions * Presence of postoperative lung collapse (confirmed by pulmonary echocardiography and Air test) * Preoperative left ventricular ejection fraction (LVEF) ≥ 30%. * Absence of hypovolemia: absence of "kissing" ventricles and/or collapsibility index of the superior vena cava \< 20%. * Stable spontaneous heart rhythm * Postoperative hemodynamic stability: * Mean arterial pressure (MAP) ≥ 60 mmHg * Central venous pressure (CVP) ≥ 10 mmHg * Heart rate (HR) ≤ 100 bpm without tachyarrhythmias * Lactic acid ≤ 3 mmol/L * Single vasopressor treatment * Norepinephrine dose ≤ 0.2 μg/kg/min, without an increase ≥ 15% in the last 30 -minutes. Obtained informed consent
Conditions3
Collapsed LungHeart DiseaseHemodynamic Stability
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorFernando Suarez Sipmann
Started2023-11-22
Est. completion2024-08
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06097026